We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGPI:NASDAQMGP Ingredients, Inc. Analysis

Data as of 2026-04-17 - not real-time

$20.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MGP Ingredients trades around $20.05, comfortably above its 20‑day SMA (18.57) but still under the 50‑day (20.57) and 200‑day (24.94) averages, indicating a short‑term bounce within a longer‑term downtrend. The RSI sits at 58, suggesting modest momentum, while the MACD histogram is positive (bullish signal) despite the MACD line remaining below the signal line. Volume has been decreasing, and the 30‑day volatility is high at ~35%, reflecting a choppy market environment. Fundamentally, the company posted a trailing EPS of –$4.99 and a profit margin of –20%, yet forward EPS is projected at $2.04, hinting at a potential earnings turnaround. The balance sheet shows $184.6 M cash against $266.6 M debt (Debt‑to‑Equity 37), and a high dividend payout ratio of 96% raises concerns about sustainability. The DCF model values the stock near $87, implying a substantial upside from current levels, while analyst consensus rates it a “strong buy” with a median target of $31. Recent material news notes a share decline to $25.87 over six months and an upcoming Q1 2026 earnings release, which could act as a catalyst for price movement.
Given the defensive consumer staples positioning, a 2.39% dividend yield, and a low beta of 0.59, the stock offers defensive characteristics but is offset by earnings volatility, high debt, and a bearish technical backdrop. Investors should weigh the attractive valuation gap and potential earnings recovery against the near‑term risk of continued price weakness and dividend sustainability concerns.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below 50‑day and 200‑day moving averages
  • Negative trailing earnings and high dividend payout ratio
  • Decreasing volume and elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Potential earnings recovery indicated by forward EPS
  • Significant valuation upside relative to DCF fair value
  • Defensive sector exposure with modest dividend yield

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF‑derived fair value suggests multi‑fold upside
  • Strategic position in premium spirits and ingredient solutions
  • Low beta and defensive consumer staples backdrop supporting stability

Key Metrics & Analysis

Financial Health

Revenue Growth-23.50%
Profit Margin-20.10%
P/E Ratio9.8
ROE-13.92%
ROA3.95%
Debt/Equity37.20
P/B Ratio0.6
Op. Cash Flow$121.5M
Free Cash Flow$155.7M

Technical Analysis

TrendBearish
RSI58.9
Support$16.45
Resistance$20.25
MA 20$18.57
MA 50$20.57
MA 200$24.94
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39

Valuation

Fair Value$87.08
Target Price$28.80
Upside/Downside43.64%
GradeUndervalued
TypeBlend
Dividend Yield2.39%

Risk Assessment

Beta0.59
Volatility34.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.